International Network of VENous Thromboembolism Clinical Research Networks


Site News
« Back to listings

INVENT endorsed HIGHLOW study (Low-Molecular-Weight Heparin to Prevent Recurrent VTE in Pregnancy: A Randomized Trial of Two Doses) has now recruited 500 patients! The study requires 500 more patients and is looking for potential sites and investigators. Click here to learn more about the study and how to participate!


There are currently no comments.

Log in to post a comment.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.